Where broad venture capital, operational and governance experience come together to catalyze, transform and invest in existing and future Life Science companies.
Employees: 1-10
Investment Type: Venture Capital
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 09.01.2023 | Amolyt Pha... | amolytphar... | $218M | France, Au... |
| 04.06.2021 | VectivBio ... | vectivbio.... | $324M | Switzerlan... |
| - | Find Thera... | findtherap... | - | - |
News 61
Show more
Mentions in press and media 20
| Date | Title | Description | Source |
| 12.01.2023 | French pharma Amolyt nets €130 million series C co-led by So... | Amolyt Pharma, an Ecully, France-based pharma startup working on rare disease treatments, has closed... | tech.eu/20... |
| 25.04.2022 | Advancing cancer treatments, medtech startup Epitopea raises... | Cambridge-based Epitopea has raised £10.3 million in a seed funding round. The medtech startup is de... | tech.eu/20... |
| 10.05.2021 | CTI Life Sciences Fund raises $100 million in first close of... | Montréal-based venture capital firm CTI Life Sciences Fund has raised $100 million CAD in the first ... | betakit.co... |
| 10.05.2021 | CTI Life Sciences Fund Successfully Raises $100 Million As A... | - | ctiscience... |
| 10.05.2021 | CTI Life Sciences Fund secures initial C$100m for third pool | - | venturecap... |
| 09.07.2020 | THE BLACKSTONE GROUP INC. Blackstone : Announces $4.6 Billi... | Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences V (“BXLS V”), the ... | marketscre... |
| 08.06.2020 | Find Therapeutics, a new drug development company dedicated ... | The new company raises initial capital to develop transmembrane peptides against GPCRs to address hi... | admarebio.... |
| 06.05.2016 | Amgen Backs New $315M Life Sciences Fund | Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-bas... | socaltech.... |
| 10.07.2015 | Xagenic Raises CAD$15M in Funding | Xagenic, a Toronto, Canada-based molecular diagnostics company developing the lab-free Xagenic X1™ p... | finsmes.co... |
| 15.01.2015 | CTI Life Sciences Raises C$134M in First Close of Second Ven... | Montreal-based CTI Life Sciences raised C$134m in the first close of its second venture fund. Limit... | finsmes.co... |
Show more